home / stock / amgn / amgn articles

AMGN Articles, Amgen Inc.

Stock Information
Company Name: Amgen Inc.
Stock Symbol: AMGN
Market: NASDAQ
Website: amgen.com
Menu
AMGN AMGN Quote AMGN Short AMGN News AMGN Articles AMGN Message Board
Get AMGN Alerts

News, Short Squeeze, Breakout and More Instantly...
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments | Benzinga

Gilead Sciences, Inc. (NASDAQ:GILD) witnessed a flurry of Wall Street speculation regarding its potential involvement in the obesity drug market. B...
Here's How Much You Would Have Made Owning Amgen Stock In The Last 20 Years | Benzinga

Amgen (NASDAQ:AMGN) has outperformed the market over the past 20 years by 1.01% on an annualized basis producing an average annual return of 8.86%....

Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug | Benzinga

Tuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to AstraZeneca Plc’s (NASDA...

What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday? | Benzinga

Thursday, Verastem Oncology (NASDAQ:VSTM) announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 t...
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $5,700 Today | Benzinga

Amgen (NASDAQ:AMGN) has outperformed the market over the past 20 years by 1.07% on an annualized basis producing an average annual return of 9.12%....

Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population | Benzinga

Sunday, Amgen Inc (NASDAQ:AMGN) and AstraZeneca Plc (NASDAQ:AZN) announced the results of the Phase 2a COURSE trial o...

Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch | Benzinga

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA)...
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly | Benzinga

The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021...

FDA Gives Accelerated Approval To Amgen's Drug For Small Cell Lung Cancer Patients | Benzinga

Thursday, the FDA approved Amgen Inc’s (NASDAQ:AMGN) Imdelltra (tarlatamab-dlle) for the treatment of adult patients with exte...

Should You Hold Viking Therapeutics in Your Portfolio? | Benzinga

Viking Therapeutics (NASDAQ: VKTX), a clinical-stage company focused on developing novel therapeutics for metabolic and endocrine disorders, has be...
Next 10